The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prospective phase II trial in patients with first relapse of high-grade astrocytoma using TVB-2640 in combination with bevacizumab versus bevacizumab alone.
 
Brandon Konkel
Stock and Other Ownership Interests - Celgene
 
Laura D Caflisch
No Relationships to Disclose
 
Adolfo Enrique Diaz Duque
No Relationships to Disclose
 
Joel Michalek
No Relationships to Disclose
 
Qianqian Liu
No Relationships to Disclose
 
Andrew Jacob Brenner
Honoraria - Vascular Biogenics
Consulting or Advisory Role - NanoTX; Vascular Biogenics
Research Funding - miRNA Therapeutics (Inst); Threshold Pharmaceuticals; Vascular Biogenics
Patents, Royalties, Other Intellectual Property - I have intellectual property interest in NanoTx Therapeutics
Travel, Accommodations, Expenses - Vascular Biogenics